- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Upcoming Dividends
Hong Kong Pharmaceuticals & Biotech Upcoming Dividends
Results
7
Companies which have announced upcoming dividend payments.
7 companies
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$5.5b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine products to wholesalers and individuals.
3613
HK$6.50
7D
-1.8%
1Y
-25.2%
Tong Ren Tang Technologies
Market Cap: HK$4.2b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$3.19
7D
-5.1%
1Y
-35.6%
Pak Fah Yeow International
Market Cap: HK$738.6m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.40
7D
-1.2%
1Y
-4.0%
Sino Biopharmaceutical
Market Cap: HK$78.8b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$4.41
7D
-4.1%
1Y
-15.8%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$1.3b
Manufactures and distributes Chinese medicines and pharmaceutical products under the Changlong and Qing Tong brands in the People’s Republic of China.
8049
HK$2.42
7D
-17.4%
1Y
14.2%
CSPC Pharmaceutical Group
Market Cap: HK$78.2b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$6.79
7D
-2.0%
1Y
-14.8%
China Resources Pharmaceutical Group
Market Cap: HK$28.2b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.44
7D
-2.4%
1Y
-15.7%